Market Cap 6.45M
Revenue (ttm) 0.00
Net Income (ttm) -38.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 17,600
Avg Vol 51,612
Day's Range N/A - N/A
Shares Out 4.16M
Stochastic %K 62%
Beta 2.25
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
USAEquityResearch
USAEquityResearch Aug. 18 at 6:11 PM
$NCNA 📊 USAEquityResearch ▼ 1.53 (-1.29%) Trend: Cautiously bullish ↗️ RSI (14): 75.8 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: 1.59 Support: 1.21 20-MA: 1.38 | 50-MA: 1.53 Educational content only. Not financial advice.
0 · Reply
nkalargyros
nkalargyros Aug. 18 at 12:59 AM
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 8:40 PM
0 · Reply
ShibWillow
ShibWillow Aug. 17 at 8:31 PM
Huge traders and influencers are on MLEC now.. its running now! @TopStockAlerts has over 105,000 Followers on Stocktwits and is now on ticker MLEC Amazing momentum.. MLEC has only 460k shares outstanding to public Looks like everyone is moving in to MLEC now! $CABA $AFRM $NCNA $DXF f
1 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Aug. 17 at 1:31 PM
$NCNA If the final data confirms that NUC-7738 + pembrolizumab works really well in PD-1-resistant melanoma, we wouldn't be talking about just another biotech.
0 · Reply
ChickenClaw
ChickenClaw Aug. 14 at 10:43 PM
$NCNA Here Come The Shorts.... Buy Low Sell High.
0 · Reply
GreenEnergy1
GreenEnergy1 Aug. 14 at 10:09 PM
$NCNA Sell, Sell, Sell… remember, buy low, sell high or in Nucana’s situation, sell anytime you can make anything back… current price is still sub $.01 prior to last years reverse split (200:1). This is not a sleeper, it’s a crasher…
1 · Reply
FickleFin
FickleFin Aug. 14 at 7:19 PM
$NCNA never invest in biotech. But i appreciate the reversal. ER was positive. Low volume. Still treading with caution. Needs a lot of recovery.
1 · Reply
Ghostalini
Ghostalini Aug. 14 at 4:00 PM
$NCNA Loving this and on a Friday too. It's a new era folks. 😎
0 · Reply
Spc_baller
Spc_baller Aug. 14 at 3:44 PM
$NCNA SLEEPING GIANT, just a matter of time, I can wait.. holdddding
0 · Reply
Latest News on NCNA
NuCana appoints Ian Webster as CFO

2026-06-01T12:43:48.000Z - 2 months ago

NuCana appoints Ian Webster as CFO


NuCana Appoints Ian Webster as Chief Financial Officer

Jun 1, 2026, 8:00 AM EDT - 2 months ago

NuCana Appoints Ian Webster as Chief Financial Officer


NuCana appoints Bruce as COO

2026-01-06T13:16:19.000Z - 8 months ago

NuCana appoints Bruce as COO


NuCana Appoints Theresa Bruce as Chief Operating Officer

Jan 6, 2026, 8:00 AM EST - 8 months ago

NuCana Appoints Theresa Bruce as Chief Operating Officer


NuCana presents latest clinical data at ESMO 2025 on NUC-7738

2025-12-10T13:15:35.000Z - 9 months ago

NuCana presents latest clinical data at ESMO 2025 on NUC-7738


NuCana presents data at ESMO on NUC-7738

2025-12-10T13:05:39.000Z - 9 months ago

NuCana presents data at ESMO on NUC-7738


NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors

2025-10-19T21:10:12.000Z - 10 months ago

NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors


NuCana announces publication of new data for NUC-3373

2025-10-14T12:16:01.000Z - 11 months ago

NuCana announces publication of new data for NUC-3373


NuCana compliant with all Nasdaq continued listing criteria

2025-09-05T12:10:43.000Z - 1 year ago

NuCana compliant with all Nasdaq continued listing criteria


NuCana Compliant with All Nasdaq Continued Listing Criteria

Sep 5, 2025, 8:00 AM EDT - 1 year ago

NuCana Compliant with All Nasdaq Continued Listing Criteria


NuCana PLC (ADR) trading halted, news pending

2025-08-08T23:50:31.000Z - 1 year ago

NuCana PLC (ADR) trading halted, news pending


NuCana announces ADS ratio change

2025-08-01T20:10:41.000Z - 1 year ago

NuCana announces ADS ratio change


NuCana Announces ADS Ratio Change

Aug 1, 2025, 4:05 PM EDT - 1 year ago

NuCana Announces ADS Ratio Change


NuCana cancels all outstanding Series A Warrants

2025-07-21T12:28:02.000Z - 1 year ago

NuCana cancels all outstanding Series A Warrants


NuCana Announces Plan to Implement ADS Ratio Change

Jul 11, 2025, 10:30 AM EDT - 1 year ago

NuCana Announces Plan to Implement ADS Ratio Change


NuCana files to sell 16.05M American Depositary Shares

2025-04-24T10:21:56.000Z - 1 year ago

NuCana files to sell 16.05M American Depositary Shares


NuCana reports  Q4  loss per share GBP (0.01) vs  GBP (.14)

2025-03-20T20:55:23.000Z - 1 year ago

NuCana reports Q4 loss per share GBP (0.01) vs GBP (.14)


NuCana Reports Q4  EPS GBP (1) vs. GBP (14)

2025-03-20T20:20:12.000Z - 1 year ago

NuCana Reports Q4 EPS GBP (1) vs. GBP (14)


NuCana reports Q3 EPS (GBP 0.07) vs (GBP 0.13) last year

2024-11-25T12:05:13.000Z - 1 year ago

NuCana reports Q3 EPS (GBP 0.07) vs (GBP 0.13) last year


Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 2 years ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares


NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:36 AM EDT - 2 years ago

NuCana to Present at the Jefferies Global Healthcare Conference


NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Listing Transfer to Nasdaq Capital Market


NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 3 years ago

NuCana to Present at the Jefferies Healthcare Conference


NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 3 years ago

NuCana Announces Receipt of Nasdaq Notice


NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 3 years ago

NuCana to Participate in Two Upcoming Investor Conferences


NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Receipt of NASDAQ Notice


USAEquityResearch
USAEquityResearch Aug. 18 at 6:11 PM
$NCNA 📊 USAEquityResearch ▼ 1.53 (-1.29%) Trend: Cautiously bullish ↗️ RSI (14): 75.8 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: below average 📌 Key Levels Resistance: 1.59 Support: 1.21 20-MA: 1.38 | 50-MA: 1.53 Educational content only. Not financial advice.
0 · Reply
nkalargyros
nkalargyros Aug. 18 at 12:59 AM
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 8:40 PM
0 · Reply
ShibWillow
ShibWillow Aug. 17 at 8:31 PM
Huge traders and influencers are on MLEC now.. its running now! @TopStockAlerts has over 105,000 Followers on Stocktwits and is now on ticker MLEC Amazing momentum.. MLEC has only 460k shares outstanding to public Looks like everyone is moving in to MLEC now! $CABA $AFRM $NCNA $DXF f
1 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Aug. 17 at 1:31 PM
$NCNA If the final data confirms that NUC-7738 + pembrolizumab works really well in PD-1-resistant melanoma, we wouldn't be talking about just another biotech.
0 · Reply
ChickenClaw
ChickenClaw Aug. 14 at 10:43 PM
$NCNA Here Come The Shorts.... Buy Low Sell High.
0 · Reply
GreenEnergy1
GreenEnergy1 Aug. 14 at 10:09 PM
$NCNA Sell, Sell, Sell… remember, buy low, sell high or in Nucana’s situation, sell anytime you can make anything back… current price is still sub $.01 prior to last years reverse split (200:1). This is not a sleeper, it’s a crasher…
1 · Reply
FickleFin
FickleFin Aug. 14 at 7:19 PM
$NCNA never invest in biotech. But i appreciate the reversal. ER was positive. Low volume. Still treading with caution. Needs a lot of recovery.
1 · Reply
Ghostalini
Ghostalini Aug. 14 at 4:00 PM
$NCNA Loving this and on a Friday too. It's a new era folks. 😎
0 · Reply
Spc_baller
Spc_baller Aug. 14 at 3:44 PM
$NCNA SLEEPING GIANT, just a matter of time, I can wait.. holdddding
0 · Reply
stockmet
stockmet Aug. 14 at 3:38 PM
$NCNA screaming buy 📈
0 · Reply
ChickenClaw
ChickenClaw Aug. 14 at 2:14 PM
$NCNA This Should Be Trading At About 450% more Just On Cash On Hand Alone!!!
0 · Reply
ChickenClaw
ChickenClaw Aug. 14 at 2:09 PM
$NCNA $19.5 Million EURO = $26.5 Million US Dollars.... That Puts This At Almost $7/ Share US...Without Patents...Just Cash On Hand!!!!!
0 · Reply
bills7765
bills7765 Aug. 14 at 11:23 AM
$NCNA constantly buying at 1.30 and 1.40 starting to look like a better idea now. We need volume to hold price though. It will go down.
0 · Reply
bills7765
bills7765 Aug. 14 at 12:20 AM
$NCNA good news today. On to the next step.
0 · Reply
Ghostalini
Ghostalini Aug. 13 at 10:06 PM
$NCNA More of this. ⬆️
0 · Reply
Letsdothis1001
Letsdothis1001 Aug. 13 at 9:55 PM
$NCNA Finally, a meaningful step in the right direction. Recent progress has come in small, if not tiny, steps. We’re still not there yet, but we’re getting closer. The fact that recruitment is now complete is encouraging. I would also assume that if patients were having significant problems tolerating NUC-7738, we likely would have seen some discontinuations or other warning signs by now. Still plenty to prove, but this feels like real progress.
0 · Reply
focafoca99
focafoca99 Aug. 13 at 8:45 PM
$NCNA presented its second-quarter 2026 financial results in a press release attached to the 6-K filing.
0 · Reply
JimmyB_And_TheBoys
JimmyB_And_TheBoys Aug. 13 at 8:31 PM
$NCNA $NCNA q2 Results • NUC-7738 Phase 2 enrollment is complete. • Indications that NUC-7738 can work on multiple tumors • Moving toward an FDA registrational strategy https://ir.nucana.com/news-releases/news-release-details/nucana-reports-second-quarter-2026-financial-results-and
0 · Reply
ChickenClaw
ChickenClaw Aug. 13 at 6:53 PM
$NCNA Madam Marie Curie.... (For Those In Panic Mode...Pun Intended)...Look Her Up... The Discovery She Helped Make And Never Got To Reap The Rewards From.... But Basically Sacrificed Her Life To Help Others...
0 · Reply
Panicmode
Panicmode Aug. 13 at 3:31 PM
$NCNA been in business for over 14yrs, founding scientist dead , drug that got this to market failed , no income. Surviving off selling shares and reverse splits to provide jobs.. Dont walk just run..
2 · Reply
CapitalMonk
CapitalMonk Aug. 13 at 3:29 AM
$NCNA Price: $1.43 (-0.69%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±340.52% RSI: 58.6 | Momentum: Moderate Volume: -55.3% vs avg Volatility: 3.52% Support: $1.21 | Resistance: $1.66 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply